Navigation Links
Sebelius Urges Americans to Get Swine Flu Vaccine
Date:10/7/2009

HHS secretary says shots are made in same way as seasonal flu vaccine, and children are vulnerable to the disease,,

WEDNESDAY, Oct. 7 (HealthDay News) -- U.S. Health and Human Services Secretary Kathleen Sebelius renewed her call Wednesday for Americans -- especially those in high-risk groups -- to get vaccinated against the H1N1 swine flu, calling the vaccine "safe and secure."

Appearing on the morning TV news programs, Sebelius reiterated her belief that the vaccine is safe, saying it "has been made exactly the same way seasonal vaccine has been made, year in and year out."

Interviewed on CBS's The Early Show, she said federal health officials have identified four groups of people at particular risk from the H1N1 swine flu: pregnant women, health-care workers, children with underlying health conditions ages 6 months to 24 years, and older Americans with underlying health conditions, such as heart disease and asthma, the Associated Press reported.

In an interview on NBC's Today show, Sebelius said children are especially vulnerable to infection from the H1N1 virus. "This flu is a younger person's flu," she said. "Kids have no immunity to the flu ... children are great carriers of bugs and viruses."

Because of the danger of easy transmission, especially in school and day-care settings, Sebelius said, "We strongly urge parents to take precautionary steps. Flu kills every year ... and we've got a great vaccine to deal with it."

Sebelius' comments echoed those of the head of the U.S. Centers for Disease Control and Prevention, Dr. Thomas R. Frieden, who said at a Tuesday afternoon press conference that the H1N1 vaccine is safe and effective with no serious side effects yet reported.

"With the production of this strain [of vaccine], we have cut no corners," Frieden said. "This flu vaccine is made as flu vaccine is made each year, by the same companies, in the same production facilities, with the same procedures, with the same safety safeguards."

"We have had hundreds of millions of people vaccinated against flu with flu vaccine made in this way. That enables us to have a high degree of confidence in the safety of the vaccine," he added.

The first shipments of the H1N1 vaccine are arriving at distribution centers throughout the country this week. These initial doses are in the form of a nasal spray (FluMist). Health-care workers, children over 2 years of age, and adults who care for infants are being encouraged to get their vaccinations now, according to the CDC.

Some two million doses of the FluMist vaccine have been shipped. The first doses of the injectable version of the vaccine will start shipping next week, Frieden said. The H1N1 virus has not mutated, he added, so the vaccine should be a good match.

Frieden noted that getting vaccine distribution up and running is a complex process and there will be glitches in the first few weeks. Already demand is outstripping supply, he said. "We expected it to be bumpy in the first few weeks," he said.

The U.S. government is still hoping to have 40 million doses of the vaccine distributed by late October and 190 million doses by year's end.

According to Frieden, one of the most common myths about getting the H1N1 vaccine is the notion that the H1N1 flu is typically mild, so it's not necessary to get vaccinated.

"Flu is not a mild illness," he said. "It can make you pretty sick, knock you out for a day or two or three, it can make you miss school and work. And for too many people it can end up sending them to the hospital, to the intensive-care unit, and, tragically, some people may die from it."

Another concern expressed by some people, Frieden said, is that the vaccine, which was rushed into testing and production after the H1N1 virus emerged last spring, may be unsafe. The H1N1 vaccine is made the same way as any other flu vaccine, Frieden said, adding that he has every confidence that it is safe.

The CDC chief pointed to what he considered another widespread misconception: Since the H1N1 flu has already started circulating in every state, it's too late to get vaccinated.

"It's too soon to say it's too late. We don't know what the rest of the season will bring," Frieden said.

In states where the H1N1 flu has been most active, it has affected about 2 percent to 5 percent of the population, leaving most people still susceptible to infection, he said.

"Flu vaccine is our best tool to protect against the flu," Frieden said.

Frieden's remarks coincided closely with statements earlier Tuesday by Gregory Hartl, a spokesman for the World Health Organization in Geneva, Switzerland. He told the Associated Press that only four of 39,000 Chinese who have received the H1N1 vaccine experienced minor side effects such as headache or muscle cramps, and these effects are to be expected.

Hartl said the current H1N1 vaccine formulation ranks among the safest the WHO has seen.

More information

For more on H1N1 swine flu, visit the CDC.



SOURCES: Oct. 6, 2009, teleconference with Thomas R. Frieden, M.D., M.P.H., director, U.S. Centers for Disease Control and Prevention, Atlanta; Associated Press


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. DGA Chair Gov. Schweitzer Applauds Gov. Sebelius Cabinet Appointment
2. UPDATED: DGA Leadership Applauds Gov. Sebelius Cabinet Appointment
3. FRC Action Questions President Obamas Choice of Gov. Sebelius for HHS
4. Americans United for Life Action: Nominating Governor Sebelius to HHS is Offensive and Divisive
5. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Gov. Sebelius for Secretary of Health and Human Services
6. Kathleen Sebelius Ready to Lead Healthcare Reform in 2009
7. Hoffa Praises Sebelius Pick for HHS Secretary
8. AHIP Statement on Governor Sebelius and Nancy-Ann DeParle
9. Operation Rescue Launches Opposition to Gov. Sebelius Confirmation as HHS Secretary
10. Pelosi Statement on President Obamas Nomination of Governor Sebelius as Secretary of HHS
11. Praise for Sebelius, DeParle From Campaign for Americas Future Co-Director Roger Hickey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology: